Literature DB >> 23414412

Insect cells as a production platform of complex virus-like particles.

Fabiana Fernandes1, Ana P Teixeira, Nuno Carinhas, Manuel J T Carrondo, Paula M Alves.   

Abstract

Virus-like particles (VLPs) are multiprotein structures that resemble the conformation of native viruses but lack a viral genome, potentiating their application as safer and cheaper vaccines. The production of VLPs has been strongly linked with the use of insect cells and the baculovirus expression vector system, especially those particles composed of two or more structural viral proteins. In fact, this expression platform has been extensively improved over the years to address the challenges of coexpression of multiple proteins and their proper assembly into complexes in the same cell. In this article, the role of insect cell technology in the development and production of complex VLPs is overviewed; recent achievements, current bottlenecks and future trends are also highlighted.

Mesh:

Substances:

Year:  2013        PMID: 23414412     DOI: 10.1586/erv.12.153

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  25 in total

1.  Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals.

Authors:  Jae-Keun Park; Dong-Hun Lee; Seong-Su Yuk; Erdene-Ochir Tseren-Ochir; Jung-Hoon Kwon; Jin-Yong Noh; Byoung-Yoon Kim; Soo-Won Choi; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

2.  Long-term, large scale cryopreservation of insect cells at -80 °C.

Authors:  Lucie Vyletova; La'Verne P Rennalls; Kirstin J L Wood; Valerie M Good
Journal:  Cytotechnology       Date:  2014-08-23       Impact factor: 2.058

3.  Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.

Authors:  Bárbara Fernandes; Ricardo Correia; Paula M Alves; António Roldão
Journal:  Front Bioeng Biotechnol       Date:  2022-06-29

Review 4.  Universal influenza vaccines: from viruses to nanoparticles.

Authors:  Ye Wang; Lei Deng; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Expert Rev Vaccines       Date:  2018-11-02       Impact factor: 5.217

5.  Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line.

Authors:  James M Wagner; J David Pajerowski; Christopher L Daniels; Patrick M McHugh; Jessica A Flynn; John W Balliet; Danilo R Casimiro; Shyamsundar Subramanian
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 6.  Self-assembling protein nanoparticles in the design of vaccines.

Authors:  Jacinto López-Sagaseta; Enrico Malito; Rino Rappuoli; Matthew J Bottomley
Journal:  Comput Struct Biotechnol J       Date:  2015-11-26       Impact factor: 7.271

Review 7.  Molecular design for recombinant adeno-associated virus (rAAV) vector production.

Authors:  Juan Jose Aponte-Ubillus; Daniel Barajas; Joseph Peltier; Cameron Bardliving; Parviz Shamlou; Daniel Gold
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-04       Impact factor: 4.813

8.  Tnao38, high five and Sf9--evaluation of host-virus interactions in three different insect cell lines: baculovirus production and recombinant protein expression.

Authors:  Monika Wilde; Miriam Klausberger; Dieter Palmberger; Wolfgang Ernst; Reingard Grabherr
Journal:  Biotechnol Lett       Date:  2013-12-29       Impact factor: 2.461

9.  Enhanced expression of full-length human cytomegalovirus fusion protein in non-swelling baculovirus-infected cells with a minimal fed-batch strategy.

Authors:  Marco Patrone; Nuno Carinhas; Marcos Q Sousa; Cristina Peixoto; Claudio Ciferri; Andrea Carfì; Paula M Alves
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles.

Authors:  Sofia B Carvalho; João M Freire; Mafalda G Moleirinho; Francisca Monteiro; Diana Gaspar; Miguel A R B Castanho; Manuel J T Carrondo; Paula M Alves; Gonçalo J L Bernardes; Cristina Peixoto
Journal:  Bioconjug Chem       Date:  2016-10-07       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.